Global HIV Medicines Production, Demand and Key Producers, 2022-2028

November 2022 | 95 pages | ID: G0E5821B4388EN
GlobalInfoResearch

Abstracts

This report studies the global HIV Medicines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for HIV Medicines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of HIV Medicines that contribute to its increasing demand across many markets.

The global HIV Medicines market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global HIV Medicines total production and demand, 2017-2028, (K Units)

Global HIV Medicines total production value, 2017-2028, (USD Million)

Global HIV Medicines production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global HIV Medicines consumption by region & country, CAGR, 2017-2028 & (K Units)

U.S. VS China: HIV Medicines domestic production, consumption, key domestic manufacturers and share

Global HIV Medicines production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)

Global HIV Medicines production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)

Global HIV Medicines production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)

This reports profiles key players in the global HIV Medicines market based on the following parameters – headquarters, production locations, products portfolio, HIV Medicines revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HIV Medicines market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global HIV Medicines Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India

Global HIV Medicines Market, Segmentation by Type

• 2 Medicines/Pill
• 3 Medicines/Pill
• 4 Medicines/Pill

Global HIV Medicines Market, Segmentation by Application

• Male
• Female

Companies Profiled:

• Gilead Sciences
• Biocon Limited
• Flamingo Pharmaceuticals Limited
• IPCA Laboratories
• Medisist Pharma
• Affine Formulations Limited

Key Questions Answered

1. How big is the global HIV Medicines market?

2. What is the demand of the global HIV Medicines market?

3. What is the year over year growth of the global HIV Medicines market?

4. What is the production and production value of the global HIV Medicines market?

5. Who are the key producers in the global HIV Medicines market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 HIV Medicines Introduction
1.2 World HIV Medicines Supply & Forecast
  1.2.1 World HIV Medicines Production Value (2017 & 2021 & 2028)
  1.2.2 World HIV Medicines Production (2017-2028)
  1.2.3 World HIV Medicines Pricing Trends (2017-2028)
1.3 World HIV Medicines Production by Region
  1.3.1 World HIV Medicines Production Value by Region (2017-2028)
  1.3.2 World HIV Medicines Production by Region (2017-2028)
  1.3.3 World HIV Medicines Average Price by Region (2017-2028)
  1.3.4 North America HIV Medicines Production (2017-2028)
  1.3.5 Europe HIV Medicines Production (2017-2028)
  1.3.6 China HIV Medicines Production (2017-2028)
  1.3.7 Japan HIV Medicines Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 HIV Medicines Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 HIV Medicines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World HIV Medicines Demand (2017-2028)
2.2 World HIV Medicines Consumption by Region
  2.2.1 World HIV Medicines Consumption by Region (2017-2022)
  2.2.2 World HIV Medicines Consumption Forecast by Region (2023-2028)
2.3 United States HIV Medicines Consumption (2017-2028)
2.4 China HIV Medicines Consumption (2017-2028)
2.5 Europe HIV Medicines Consumption (2017-2028)
2.6 Japan HIV Medicines Consumption (2017-2028)
2.7 South Korea HIV Medicines Consumption (2017-2028)
2.8 ASEAN HIV Medicines Consumption (2017-2028)
2.9 India HIV Medicines Consumption (2017-2028)

3 WORLD HIV MEDICINES MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World HIV Medicines Production Value by Manufacturer (2017-2022)
3.2 World HIV Medicines Production by Manufacturer (2017-2022)
3.3 World HIV Medicines Average Price by Manufacturer (2017-2022)
3.4 HIV Medicines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global HIV Medicines Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for HIV Medicines in 2021
  3.5.3 Global Concentration Ratios (CR8) for HIV Medicines in 2021
3.6 HIV Medicines Market: Overall Company Footprint Analysis
  3.6.1 HIV Medicines Market: Region Footprint
  3.6.2 HIV Medicines Market: Company Product Type Footprint
  3.6.3 HIV Medicines Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: HIV Medicines Production Value Comparison
  4.1.1 United States VS China: HIV Medicines Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: HIV Medicines Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: HIV Medicines Production Comparison
  4.2.1 United States VS China: HIV Medicines Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: HIV Medicines Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: HIV Medicines Consumption Comparison
  4.3.1 United States VS China: HIV Medicines Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: HIV Medicines Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States HIV Medicines Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of HIV Medicines in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States HIV Medicines Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States HIV Medicines Production by Domestic Manufacturer, (2017-2022)
4.5 China HIV Medicines Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of HIV Medicines in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China HIV Medicines Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China HIV Medicines Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World HIV Medicines Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of HIV Medicines in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World HIV Medicines Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World HIV Medicines Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY TYPE

5.1 World HIV Medicines Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
  5.2.1 2 Medicines/Pill
  5.2.2 3 Medicines/Pill
  5.2.3 4 Medicines/Pill
5.3 Market Segment by Type
  5.3.1 World HIV Medicines Production by Type (2017-2028)
  5.3.2 World HIV Medicines Production Value by Type (2017-2028)
  5.3.3 World HIV Medicines Average Price by Type (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World HIV Medicines Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Male
  6.2.2 Female
6.3 Market Segment by Application
  6.3.1 World HIV Medicines Production by Application (2017-2028)
  6.3.2 World HIV Medicines Production Value by Application (2017-2028)
  6.3.3 World HIV Medicines Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Details
  7.1.2 Gilead Sciences Major Business
  7.1.3 Gilead Sciences HIV Medicines Product and Services
  7.1.4 Gilead Sciences HIV Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Gilead Sciences Recent Developments/Updates
  7.1.6 Gilead Sciences Competitive Strengths & Weaknesses
7.2 Biocon Limited
  7.2.1 Biocon Limited Details
  7.2.2 Biocon Limited Major Business
  7.2.3 Biocon Limited HIV Medicines Product and Services
  7.2.4 Biocon Limited HIV Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 Biocon Limited Recent Developments/Updates
  7.2.6 Biocon Limited Competitive Strengths & Weaknesses
7.3 Flamingo Pharmaceuticals Limited
  7.3.1 Flamingo Pharmaceuticals Limited Details
  7.3.2 Flamingo Pharmaceuticals Limited Major Business
  7.3.3 Flamingo Pharmaceuticals Limited HIV Medicines Product and Services
  7.3.4 Flamingo Pharmaceuticals Limited HIV Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 Flamingo Pharmaceuticals Limited Recent Developments/Updates
  7.3.6 Flamingo Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.4 IPCA Laboratories
  7.4.1 IPCA Laboratories Details
  7.4.2 IPCA Laboratories Major Business
  7.4.3 IPCA Laboratories HIV Medicines Product and Services
  7.4.4 IPCA Laboratories HIV Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.4.5 IPCA Laboratories Recent Developments/Updates
  7.4.6 IPCA Laboratories Competitive Strengths & Weaknesses
7.5 Medisist Pharma
  7.5.1 Medisist Pharma Details
  7.5.2 Medisist Pharma Major Business
  7.5.3 Medisist Pharma HIV Medicines Product and Services
  7.5.4 Medisist Pharma HIV Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.5.5 Medisist Pharma Recent Developments/Updates
  7.5.6 Medisist Pharma Competitive Strengths & Weaknesses
7.6 Affine Formulations Limited
  7.6.1 Affine Formulations Limited Details
  7.6.2 Affine Formulations Limited Major Business
  7.6.3 Affine Formulations Limited HIV Medicines Product and Services
  7.6.4 Affine Formulations Limited HIV Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.6.5 Affine Formulations Limited Recent Developments/Updates
  7.6.6 Affine Formulations Limited Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of HIV Medicines and Key Manufacturers
8.2 HIV Medicines Manufacturing Costs
8.3 HIV Medicines Production Process
8.4 HIV Medicines Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for HIV Medicines Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 HIV Medicines Typical Distributors
9.3 HIV Medicines Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World HIV Medicines Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World HIV Medicines Production Value by Region (2017-2022) & (USD Million)
Table 3. World HIV Medicines Production Value by Region (2023-2028) & (USD Million)
Table 4. World HIV Medicines Production Value Market Share by Region (2017-2022)
Table 5. World HIV Medicines Production Value Market Share by Region (2023-2028)
Table 6. World HIV Medicines Production by Region (2017-2022) & (K Units)
Table 7. World HIV Medicines Production by Region (2023-2028) & (K Units)
Table 8. World HIV Medicines Production Market Share by Region (2017-2022)
Table 9. World HIV Medicines Production Market Share by Region (2023-2028)
Table 10. World HIV Medicines Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World HIV Medicines Average Price by Region (2023-2028) & (US$/Unit)
Table 12. HIV Medicines Major Market Trends
Table 13. World HIV Medicines Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World HIV Medicines Consumption by Region (2017-2022) & (K Units)
Table 15. World HIV Medicines Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World HIV Medicines Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key HIV Medicines Producers in 2021
Table 18. World HIV Medicines Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key HIV Medicines Producers in 2021
Table 20. World HIV Medicines Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global HIV Medicines Company Evaluation Quadrant
Table 22. World HIV Medicines Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and HIV Medicines Production Site of Key Manufacturer
Table 24. HIV Medicines Market: Company Product Type Footprint
Table 25. HIV Medicines Market: Company Product Application Footprint
Table 26. HIV Medicines Competitive Factors
Table 27. HIV Medicines New Entrant and Capacity Expansion Plans
Table 28. HIV Medicines Mergers & Acquisitions Activity
Table 29. United States VS China HIV Medicines Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China HIV Medicines Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China HIV Medicines Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of HIV Medicines in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States HIV Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States HIV Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States HIV Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States HIV Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of HIV Medicines in China, Company Headquarters and Production Place (Province, Country)
Table 38. China HIV Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China HIV Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China HIV Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China HIV Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of HIV Medicines in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World HIV Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World HIV Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World HIV Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World HIV Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World HIV Medicines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World HIV Medicines Production by Type (2017-2022) & (K Units)
Table 49. World HIV Medicines Production by Type (2023-2028) & (K Units)
Table 50. World HIV Medicines Production Value by Type (2017-2022) & (USD Million)
Table 51. World HIV Medicines Production Value by Type (2023-2028) & (USD Million)
Table 52. World HIV Medicines Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World HIV Medicines Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World HIV Medicines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World HIV Medicines Production by Application (2017-2022) & (K Units)
Table 56. World HIV Medicines Production by Application (2023-2028) & (K Units)
Table 57. World HIV Medicines Production Value by Application (2017-2022) & (USD Million)
Table 58. World HIV Medicines Production Value by Application (2023-2028) & (USD Million)
Table 59. World HIV Medicines Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World HIV Medicines Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 62. Gilead Sciences Major Business
Table 63. Gilead Sciences HIV Medicines Product and Services
Table 64. Gilead Sciences HIV Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Gilead Sciences Recent Developments/Updates
Table 66. Gilead Sciences Competitive Strengths & Weaknesses
Table 67. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 68. Biocon Limited Major Business
Table 69. Biocon Limited HIV Medicines Product and Services
Table 70. Biocon Limited HIV Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Biocon Limited Recent Developments/Updates
Table 72. Biocon Limited Competitive Strengths & Weaknesses
Table 73. Flamingo Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 74. Flamingo Pharmaceuticals Limited Major Business
Table 75. Flamingo Pharmaceuticals Limited HIV Medicines Product and Services
Table 76. Flamingo Pharmaceuticals Limited HIV Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Flamingo Pharmaceuticals Limited Recent Developments/Updates
Table 78. Flamingo Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 79. IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table 80. IPCA Laboratories Major Business
Table 81. IPCA Laboratories HIV Medicines Product and Services
Table 82. IPCA Laboratories HIV Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. IPCA Laboratories Recent Developments/Updates
Table 84. IPCA Laboratories Competitive Strengths & Weaknesses
Table 85. Medisist Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Medisist Pharma Major Business
Table 87. Medisist Pharma HIV Medicines Product and Services
Table 88. Medisist Pharma HIV Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Medisist Pharma Recent Developments/Updates
Table 90. Affine Formulations Limited Basic Information, Manufacturing Base and Competitors
Table 91. Affine Formulations Limited Major Business
Table 92. Affine Formulations Limited HIV Medicines Product and Services
Table 93. Affine Formulations Limited HIV Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 94. HIV Medicines Raw Material
Table 95. Key Manufacturers of HIV Medicines Raw Materials
Table 96. HIV Medicines Typical Distributors
Table 97. HIV Medicines Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. HIV Medicines Picture
Figure 2. World HIV Medicines Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World HIV Medicines Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World HIV Medicines Production (2017-2028) & (K Units)
Figure 5. World HIV Medicines Average Price (2017-2028) & (US$/Unit)
Figure 6. World HIV Medicines Production Value Market Share by Region (2017-2028)
Figure 7. World HIV Medicines Production Market Share by Region (2017-2028)
Figure 8. North America HIV Medicines Production (2017-2028) & (K Units)
Figure 9. Europe HIV Medicines Production (2017-2028) & (K Units)
Figure 10. China HIV Medicines Production (2017-2028) & (K Units)
Figure 11. Japan HIV Medicines Production (2017-2028) & (K Units)
Figure 12. HIV Medicines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World HIV Medicines Demand (2017-2028) & (K Units)
Figure 15. World HIV Medicines Consumption Market Share by Region (2017-2028)
Figure 16. United States HIV Medicines Consumption (2017-2028) & (K Units)
Figure 17. China HIV Medicines Consumption (2017-2028) & (K Units)
Figure 18. Europe HIV Medicines Consumption (2017-2028) & (K Units)
Figure 19. Japan HIV Medicines Consumption (2017-2028) & (K Units)
Figure 20. South Korea HIV Medicines Consumption (2017-2028) & (K Units)
Figure 21. ASEAN HIV Medicines Consumption (2017-2028) & (K Units)
Figure 22. India HIV Medicines Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of HIV Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for HIV Medicines Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for HIV Medicines Markets in 2021
Figure 26. United States VS China: HIV Medicines Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: HIV Medicines Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: HIV Medicines Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of HIV Medicines in United States
Figure 30. Key Producers and Market Share of HIV Medicines in China
Figure 31. Key Producers and Market Share of HIV Medicines in Rest of World
Figure 32. World HIV Medicines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World HIV Medicines Production Value Market Share by Type in 2021
Figure 34. 2 Medicines/Pill
Figure 35. 3 Medicines/Pill
Figure 36. 4 Medicines/Pill
Figure 37. World HIV Medicines Production Market Share by Type (2017-2028)
Figure 38. World HIV Medicines Production Value Market Share by Type (2017-2028)
Figure 39. World HIV Medicines Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World HIV Medicines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World HIV Medicines Production Value Market Share by Application in 2021
Figure 42. Male
Figure 43. Female
Figure 44. World HIV Medicines Production Market Share by Application (2017-2028)
Figure 45. World HIV Medicines Production Value Market Share by Application (2017-2028)
Figure 46. World HIV Medicines Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of HIV Medicines in 2021
Figure 48. Manufacturing Process Analysis of HIV Medicines
Figure 49. HIV Medicines Industrial Chain
Figure 50. Distribution Channel Breakdown for HIV Medicines Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source